Replies to post #86032 on PharmaCyte Biotech Inc (PMCB)

[1234jklm]

Thanks Vinnie.

Now if only we could get the management to be a bit more driven ... but I do believe we are very close.

Yes I think this could become the favored pre op therapy for most cancerous tumors before long.

Being able to inject the cypcaps in some cases makes it even more affordable. And the operations smaller which brings better results.

If we don’t see much progress on the next pr and more money being given to Austrianova I think we should all group email Thomas Yuen our board member and ask him to call a shareholder meeting.

What I don’t understand is why Austrianova has to be paid so much when we are making their therapy so valuable for them. Not a great deal imho.